Sanofi Partnering Event with Biocom & MassBio

Sanofi Partnering Event with Biocom & MassBio

On Friday, October 16th, 2020 Sanofi will provide an overview of its research & development organization, corporate development strategy, business areas and its novel and fully integrated approaches to partnering. There will be an opportunity to request 1-on-1 meetings with Sanofi in the area of: Oncology, Immunology & Inflammation, Rare Blood Disorders, Rare & Neurological Diseases, Digital and Vaccines.

Sanofi is transforming its R&D organization to focus on the development of first-in-class or best-in-class medicines and leverage innovative technology platforms that can help maximize potential patient benefit.

Science is fueled by collaboration, and Sanofi has a keen understanding of what can be achieved by coming together across sectors and borders. The company’s diverse approach to partnering is intended to lay the foundation for next-generation therapeutics discovery and development and build a sustainable network for innovation, to make a difference for patients now and in the future.

Areas of Focus & 1-on-1 Meetings:

As Sanofi helps to shape a new era in medicine, it is embracing strategic partnerships and collaborations that align science and talent with opportunity. The company seeks out individuals and companies with complementary assets, platforms or skill sets that will contribute to the creation of a powerful R&D engine and robust pipeline of potential first-in-class and best-in-class medicines.

The goal is to stay ahead of the curve, nurturing the development of the next technology or novel approaches while taking smart risks. The company is eager to join forces with pioneering external partners to continually build expertise from discovery through development in areas including: Oncology, Immunology & Inflammation, Rare Blood Disorders, Rare & Neurological Diseases, Digital and Vaccines.

Please click here (Focus Areas) for a more detailed list of interest areas.